Digest Network Come funziona
Network
/
Società
T-
Non verificato

T-knife Therapeutics

Di cosa scriviamo

Annunci EconomiciBiotecnologiaMedicina Salute Benessere

9 comunicati stampa

Guarda tutti i comunicati
03/03/2026
Biotecnologia
Annunci Economici
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
17/11/2025
Biotecnologia
T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
07/11/2025
Biotecnologia
Medicina Salute Benessere
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
07/10/2025
Biotecnologia
Medicina Salute Benessere
T-knife Therapeutics Presents Preclinical Data Highlighting the Transformative Potential of the MyT™ Platform to Discover and Develop Next-Generation TCR Therapies to Treat Solid Tumors at the European Society of Gene & Cell Therapy (ESGCT) 2025 Annual Congress
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
01/07/2025
Biotecnologia
T-knife Therapeutics Appoints Christoph Broja to its Board of Directors
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
25/04/2025
Biotecnologia
Medicina Salute Benessere
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
25/03/2025
Biotecnologia
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
20/02/2025
Biotecnologia
T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
12/02/2025
Biotecnologia
T-knife Therapeutics to Participate in Two Investor Conferences in March 
Fonte
T-knife Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0